Listed

Shuttle Pharmaceuticals Holdings, Inc.

SHPHNasdaqCIK 1757499HealthcareFiscal year ends Dec 31

Reports and events: 148 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Shuttle Pharmaceuticals Holdings, Inc., Reports and events
FiledFormWhat it isAccession number
2025-04-0416:10 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001641172-25-002757
2025-03-3117:27 ETDEF 14AProxy statementPeriod 2025-03-310001641172-25-001889
2025-03-3117:25 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001641172-25-001880
2025-03-2516:10 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001641172-25-000595
2025-03-1316:19 ET8-K1.01 Entry into a material agreement; 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-25-010211
2025-03-1206:20 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-25-009922
2025-03-0506:48 ETS-1/ARegistration statement, amended0001493152-25-009106
2025-02-2817:24 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-25-008742
2025-02-2708:38 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-25-008462
2025-02-2610:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-25-008306
2025-02-2610:20 ET10-KAnnual reportPeriod 2024-12-310001493152-25-008300
2025-02-1306:22 ETS-1Registration statement0001493152-25-006202
2025-01-2816:10 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-25-003985
2025-01-2109:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-25-002945
2025-01-1506:37 ETS-1Registration statement0001493152-25-002253
2025-01-0709:00 ET8-K3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-25-001132
2024-12-1909:00 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-050700
2024-11-2609:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-047747
2024-11-1317:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-045199
2024-11-1317:01 ET10-QQuarterly reportPeriod 2024-09-300001493152-24-045176
2024-11-0120:57 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-043249
2024-10-2909:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-042786
2024-10-2816:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-042677
2024-10-2809:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-042614
2024-10-2508:52 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-24-042462
2024-10-1809:06 ETS-1/ARegistration statement, amended0001493152-24-041510
2024-10-1717:17 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-24-041443
2024-09-2006:04 ETS-1Registration statement0001493152-24-037194
2024-09-1317:00 ET8-K3.01 Delisting notice0001493152-24-036223
2024-09-1017:23 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-24-035667
2024-09-0416:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-034987
2024-09-0421:54 ET10-QQuarterly reportPeriod 2024-06-300001493152-24-034902
2024-09-0421:52 ET10-Q/AQuarterly report, amendedPeriod 2024-03-310001493152-24-034901
2024-09-0421:51 ET10-K/AAnnual report, amendedPeriod 2023-12-310001493152-24-034898
2024-08-2809:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-034124
2024-08-2616:10 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001493152-24-033876
2024-08-1416:15 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-032218
2024-08-0708:00 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-030491
2024-08-0109:45 ET8-K5.07 Shareholder vote results0001493152-24-029882
2024-07-1616:59 ET8-K4.02 Non-reliance on financial statements0001493152-24-028031
2024-06-2015:59 ETDEF 14AProxy statementPeriod 2024-06-200001493152-24-024491
2024-06-1809:00 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-024224
2024-05-2216:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-021015
2024-05-1409:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-019097
2024-05-1317:01 ET10-QQuarterly reportPeriod 2024-03-310001493152-24-018944
2024-04-2910:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-016875
2024-04-2316:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-015703
2024-04-0517:06 ETS-1Registration statement0001493152-24-013368
2024-03-2209:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-010919
2024-03-2117:28 ET10-KAnnual reportPeriod 2023-12-310001493152-24-010822

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 18:28 ET. Listed shows no prices and gives no investment advice.